Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market to Reach $692.3 Million by 2030
The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) estimated at US$519.4 Million in the year 2022, is projected to reach a revised size of US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. ELISA Kits, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$478.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the ELISA Development Sets & Antibody Pairs segment is readjusted to a revised 4.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $141.5 Million, While China is Forecast to Grow at 6.1% CAGR
The Research ELISA (Enzyme-Linked Immunosorbent Assay) market in the U.S. is estimated at US$141.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$140.2 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 3.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.Select Competitors (Total 27 Featured) -
- American Laboratory Products Company (ALPCO) (US)
- BD Biosciences (US)
- BioLegend, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Enzo Life Sciences, Inc. (US)
- Merck KGaA
- Mercodia AB (Sweden)
- R&D Systems, Inc. (US)
- Thermo Fischer Scientific Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- ELISA - A Renowned and Proven Assay Format
- Recent Market Activity
- Current and Future Analysis
- Factors Sustaining Market Growth
- Factors Restraining Growth
- ELISA Amid A Challenging Environment
- Strategies to Counter Competition
- Technological Advances to Buoy ELISA’s Prospects
- Automation of ELISA - Enabling its Sustenance
- Growing Popularity of Multiplexing Deters ELISA Market
- Commoditization: A Key Issue Facing ELISA Product Manufacturers
- Limited ELISA Application in the Food Industry
- Available Test Kits at External Laboratories by Allergen
- Competitive Landscape
- Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
- American Laboratory Products Company (ALPCO) (USA
- BD Biosciences (USA)
- BioLegend, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Enzo Life Sciences, Inc. (USA)
- Merck KgaA (Germany)
- Mercodia AB (Sweden)
- R&D Systems, Inc. (USA)
- Thermo Fisher Scientific, Inc. (USA)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 3: World 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for ELISA Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 6: World 18-Year Perspective for ELISA Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for ELISA Development Sets & Antibody Pairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 9: World 18-Year Perspective for ELISA Development Sets & Antibody Pairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 12: World 18-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 15: World 18-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
- Table 16: World Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2030
UNITED STATES
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 17: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 18: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 19: USA 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 20: USA Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 21: USA Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 22: USA 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
CANADA
- Table 23: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 25: Canada 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 26: Canada Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 27: Canada Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 28: Canada 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
JAPAN
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 29: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 30: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 31: Japan 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 32: Japan Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: Japan Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 34: Japan 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
CHINA
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 35: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 37: China 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 38: China Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: China Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 40: China 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
EUROPE
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 41: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 42: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 43: Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
- Table 44: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 45: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 46: Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 47: Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 48: Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 49: Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
FRANCE
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 50: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 52: France 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 53: France Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 54: France Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 55: France 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
GERMANY
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 56: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 57: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 58: Germany 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 59: Germany Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: Germany Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 61: Germany 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
ITALY
- Table 62: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 64: Italy 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 65: Italy Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: Italy Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 67: Italy 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
UNITED KINGDOM
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 68: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 70: UK 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 71: UK Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 72: UK Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 73: UK 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
SPAIN
- Table 74: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 75: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 76: Spain 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 77: Spain Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: Spain Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 79: Spain 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
RUSSIA
- Table 80: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 82: Russia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 83: Russia Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Russia Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 85: Russia 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
REST OF EUROPE
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 88: Rest of Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 89: Rest of Europe Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 90: Rest of Europe Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 91: Rest of Europe 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
ASIA-PACIFIC
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 93: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 94: Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
- Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 96: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - ELISA Kits and ELISA Development Sets & Antibody Pairs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 97: Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by Segment - Percentage Breakdown of Value Sales for ELISA Kits and ELISA Development Sets & Antibody Pairs for the Years 2012, 2023 & 2030
- Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 99: Asia-Pacific Historic Review for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Hospitals & Diagnostic Centers and Research Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
- Table 100: Asia-Pacific 18-Year Perspective for Research ELISA (Enzyme-Linked Immunosorbent Assay) by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers and Research Laboratories for the Years 2012, 2023 & 2030
AUSTRALIA
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
LATIN AMERICA
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
MIDDLE EAST
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
AFRICA
- Research ELISA (Enzyme-Linked Immunosorbent Assay) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- American Laboratory Products Company (ALPCO) (US)
- BD Biosciences (US)
- BioLegend, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Enzo Life Sciences, Inc. (US)
- Merck KGaA
- Mercodia AB (Sweden)
- R&D Systems, Inc. (US)
- Thermo Fischer Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 266 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 519.4 Million |
| Forecasted Market Value ( USD | $ 692.3 Million |
| Compound Annual Growth Rate | 3.7% |
| Regions Covered | Global |
